← Back to Search

Procedure

Rehabilitation after Surgery for Spinal Cord Injury

Phase 2
Recruiting
Research Sponsored by Burke Medical Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Motor incomplete or complete lesion (measured by the ASIA Impairment Scale, A, B, C, D).
Demonstrate stability of motor examination for at least six months.
Timeline
Screening 3 days
Treatment 6 weeks
Follow Up 1 year post surgery, immediately post training, minus baseline before surgery
Awards & highlights

Summary

This trial is testing if using robots for intense physical therapy can help tetraplegic patients regain hand and arm function after nerve transfer surgery. The therapy aims to retrain the brain to use new nerve connections effectively. Robot-assisted therapy has shown promise in improving upper limb function in patients with neurological impairments, including those with chronic stroke.

Who is the study for?
This trial is for individuals with tetraplegia due to spinal cord injury who have stable motor function and can consent to the study. They must have specific muscle strength, intact nerve connections as confirmed by tests, and a caregiver for post-surgery therapy. Those with seizure history, metal implants affecting brain stimulation, or unsuitable for surgery are excluded.
What is being tested?
The study examines how robot-assisted rehabilitation after nerve transfer surgery affects hand function and brain activity in patients with spinal cord injuries. The effectiveness will be measured using clinical assessments of hand/arm function and Transcranial Magnetic Stimulation (TMS) mapping.
What are the potential side effects?
Potential side effects may include discomfort from TMS, surgical risks like infection or poor wound healing, possible pain during rehabilitation exercises, and fatigue associated with intensive physical therapy.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My spinal cord injury is classified as A, B, C, or D on the ASIA scale.
Select...
Your motor abilities have not changed for at least six months.
Select...
My paralyzed muscles can still respond to nerve signals.
Select...
My muscles controlled by the nerves for the planned transfer are strong and well-functioning.
Select...
I have someone at home to help me with physical therapy after surgery.

Timeline

Screening ~ 3 days
Treatment ~ 6 weeks
Follow Up ~1 year post surgery, immediately post training, minus baseline before surgery
This trial's timeline: 3 days for screening, 6 weeks for treatment, and 1 year post surgery, immediately post training, minus baseline before surgery for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Box and Blocks test score
Secondary study objectives
Modified Ashworth Scale
Single pulse transcranial magnetic stimulation
Spinal Cord Independence Measure (SCIM III)
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Nerve transfer + robotic trainingExperimental Treatment2 Interventions
Participants will receive nerve transfer surgery at Massachusetts General Hospital in Boston, MA. One year after the surgery, participants will receive six weeks of upper limb robotic training at the Burke Neurological Institute in White Plains, NY.
Group II: Nerve transfer + delayed robotic trainingActive Control2 Interventions
Participants will receive nerve transfer surgery at Massachusetts General Hospital in Boston, MA. One year + six weeks after the surgery, participants will receive six weeks of upper limb robotic training at the Burke Neurological Institute in White Plains, NY.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for spinal cord injury (SCI) include robot-assisted, intensive rehabilitation, which supports the return of hand and arm function and strengthens cortical representations of targeted muscles. This treatment works by providing repetitive, task-specific training that promotes neuroplasticity, the brain's ability to reorganize itself by forming new neural connections. This is crucial for SCI patients as it can lead to improved motor function and independence. Additionally, other treatments like constraint-induced movement therapy and functional electrical stimulation also aim to enhance neuroplasticity and muscle strength, further aiding in the recovery of motor skills and overall quality of life for SCI patients.
Motor Restoration and Spasticity Management after Stroke.

Find a Location

Who is running the clinical trial?

Burke Medical Research InstituteLead Sponsor
23 Previous Clinical Trials
1,453 Total Patients Enrolled
Massachusetts General HospitalOTHER
2,955 Previous Clinical Trials
13,212,666 Total Patients Enrolled

Media Library

Nerve transfer surgery (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT04041063 — Phase 2
Spinal Cord Injury Research Study Groups: Nerve transfer + robotic training, Nerve transfer + delayed robotic training
Spinal Cord Injury Clinical Trial 2023: Nerve transfer surgery Highlights & Side Effects. Trial Name: NCT04041063 — Phase 2
Nerve transfer surgery (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04041063 — Phase 2
Spinal Cord Injury Patient Testimony for trial: Trial Name: NCT04041063 — Phase 2
~2 spots leftby Dec 2025